Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026)
Envista Holdings (NVST) posted quarterly Other Non-Current Assets of $223.8 million for Q2 2026, down 8.54% year-over-year from $244.7 million in Q2 2025, and down 1.89% quarter-over-quarter from $228.1 million in Q4 2025.
Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Envista Holdings' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $223.8 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 8.54% year-over-year to $223.8 million; the TTM figure through Apr 2026 stood at $223.8 million (down 8.54% YoY), while the FY2025 annual figure was $228.1 million, down 1.08% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $223.8 million, down from $228.1 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $264.9 million in Q2 2025, with the low at $4.1 million in Q3 2022.
- The 5-year median for Other Non-Current Assets is $180.5 million (2023), against an average of $190.3 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets plunged 97.21% in 2022, then surged 3600.0% in 2023.
- Envista Holdings' Other Non-Current Assets stood at $153.7 million in 2022, then advanced by 17.44% to $180.5 million in 2023, then advanced by 27.76% to $230.6 million in 2024, then decreased by 1.08% to $228.1 million in 2025, then fell by 1.89% to $223.8 million in 2026.
- Business Quant data shows NVST's Other Non-Current Assets at $223.8 million in Q2 2026, $228.1 million in Q4 2025, and $249.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 230.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 230.40 Mn |
| Apr 3, 2026 | 223.80 Mn |
| Dec 31, 2025 | 228.10 Mn |
| Sep 26, 2025 | 249.30 Mn |
| Jun 27, 2025 | 264.90 Mn |
| Mar 28, 2025 | 244.70 Mn |
| Dec 31, 2024 | 230.60 Mn |
| Sep 27, 2024 | 250.60 Mn |
| Jun 28, 2024 | 218.60 Mn |
| Mar 29, 2024 | 174.40 Mn |
| Dec 31, 2023 | 180.50 Mn |
| Sep 29, 2023 | 152.90 Mn |
| Jun 30, 2023 | 151.70 Mn |
| Mar 31, 2023 | 158.30 Mn |
| Dec 31, 2022 | 153.70 Mn |
| Sep 30, 2022 | 173.20 Mn |
| Jul 1, 2022 | 4.10 Mn |
| Apr 1, 2022 | 174.90 Mn |
| Dec 31, 2021 | 167.80 Mn |
| Jul 2, 2021 | 147.00 Mn |